Policy | July 14, 2024
7th India-Japan medical product regulatory symposium held at New Delhi
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
